## Note
nid: 1587683387014
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#AMBOSS, #AK_Step1_v11::#AMBOSS::Respiratory, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::10_Sympathomimetics::Direct, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::10_Sympathomimetics::Indirect::Phentermine_Diethylpropion_Benzphentamine, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#UWorld::10000-99999::18000-18999::18595, #AK_Step1_v11::$AnKingAdds::UWorld, #AK_Step1_v11::^Other::^HighYield::4-LowerYield, #AK_Step2_v11::#AMBOSS, #AK_Step2_v11::#AMBOSS::IM
markdown: false

### Text
<b>Phentermine, diethylpropion,</b> and <b>benzphetamine</b> are
{{c1::sympathomimetic::MOA}} drugs used for {{c2::weight loss}}

### Extra
These are <u>norepinephrine-releasing agents</u> and thus
contraindicated in patients with CVD, hypertension or HF
<div>
  Poor long-term success. Most patients regain weight after
  discontinuation.
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

